Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
The second day of the AACR Virtual Annual Meeting II began with a clinical trials plenary session. Two of the session’s presentations, which focused on immunotherapy clinical...
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
The Opening Ceremony of the American Association for Cancer Research (AACR) Virtual Annual Meeting II provided a stark reminder that...
This year alone, an estimated 1.8 million people will hear their doctor say they have cancer. The individual impact...
On April 27, cancer researchers, health care professionals, patients, advocates, and policymakers around the world logged on to their...
Immunotherapy research has exploded over the past decade and has led to the approval of seven immune checkpoint inhibitors by the United States Food and Drug Administration (FDA) for the treatment...
In the early 1990s, Gregg Semenza, MD, PhD, was a postdoctoral researcher studying the cellular response to reduced oxygen levels, a...
Every month, the editors from the portfolio of scientific journals published by the AACR select one “must read” article...
The days are getting longer and warmer, and visions of beach trips, cookouts, and picnics occupy our minds. While this year’s summer will likely look different due to the ongoing COVID-19 pandemic, months...
Just over a month ago, the American Association for Cancer Research (AACR) held the first portion of its Annual...